Journal Guide

F1000Research is an Open Research publishing platform for life scientists, offering immediate publication of articles and other research outputs without editorial bias. All articles benefit from transparent refereeing and the inclusion of all source data.

FASEB BioAdvances is an international open-access journal of the Federation of American Societies for Experimental Biology (FASEB) published in partnership with John Wiley and Sons. Founded in 1912, FASEB is the nation’s largest federation of U.S. biomedical societies, representing more than 130,000 researchers worldwide.

FASEB BioAdvances serves the global bioscience community by providing a vehicle for publishing well-designed and executed original research, review, and hypothesis papers, as well as reports on the replication of other published work—regardless of perceived or anticipated citation “impact.” Published articles must be of credible design and sound science.

FEBS Letters is one of the world's leading journals in biochemistry and is renowned both for its quality of content and speed of production. Bringing together the most important developments in the molecular biosciences, FEBS Letters provides an international forum for Minireviews, hypotheses and research letters that merit urgent publication.FEBS Letters offers:• Faster publication: - Accepted articles are published online in 3 days - The print version of the article is published in 3 to 5 weeks after acceptance• Full-text article disclosure in HTML and PDF formats• Articles in Press are included in PubMed• Easy online manuscript submission system• Transparent online peer review and manuscript tracking system• No page charges• Free color figuresSubject Coverage:The subject area of FEBS Letters is broad. It covers biochemistry (including protein chemistry, enzymology, nucleic acid chemistry, metabolism, and immunochemistry), structural biology, biophysics, computational biology (genomics, proteomics, bioinformatics), molecular genetics, molecular biology and molecular cell biology (signal transduction, intracellular traffic, regulation of cellular proliferation, cell-cell interactions) and systems biology. Studies on microbes, plants and animals at the molecular level are within the scope of FEBS Letters.Submitting Authors:Manuscripts can be submitted to FEBS Letters at: http://ees.elsevier.com/febsletters/

FEBS Open Bio is an online-only Open Access journal for the rapid publication of research articles in molecular and cellular life sciences in both health and disease. The journal's peer review process focuses on the technical soundness of papers, leaving the assessment of their impact and importance to the scientific community. FEBS Open Bio is published by Elsevier on behalf of the Federation of European Biochemical Societies (FEBS), a charity whose objectives are to promote research and education in the molecular life sciences. Any income from the journal will be used to support scientists through fellowships, courses, travel grants, prizes and other FEBS initiatives. FEBS Open Bio publishes experimental findings, critical analysis, methodological and technical innovations, and hypotheses. Novel or innovative work is encouraged, but papers describing sound science of a confirmatory nature in developing fields or extending knowledge of an important topic from one organism to another will also be considered. Articles originally submitted to other FEBS publications (FEBS Letters, FEBS Journal and Molecular Oncology) can be transferred for consideration by FEBS Open Bio with their original reviewer reports, without the need to resubmit or reformat the manuscript. FEBS Open Bio offers: Easy online manuscript submission and tracking system Fast and helpful peer review - median time to first decision 20 days Transfer service for articles from other FEBS journals, conserving peer reviews Fast publication Accepted articles published online within 5 days Author-corrected final version available within 20 days All articles are deposited in PubMed Central and indexed in PubMed